Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of Ribavirin Pretreatment in Chronic HCV Genotype 1
NCT02716779Phase 2Completed
- Sponsor
- Roche
- Start
- Apr 2007
- Primary completion
- Apr 2010
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of ribavirin in hepatitis C (HCV), sponsored by Roche. Started Apr 2007; status: completed.
02
Drugs
ribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02716779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02716779.